@Springer_Med Avatar @Springer_Med Springer Medicine

Springer Medicine posts on X about how can, what are, can you, to the the most. They currently have [-----] followers and [---] posts still getting attention that total [-------] engagements in the last [--] hours.

Engagements: [-------] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [------] #

CreatorRank Line Chart

Social Influence

Social category influence currencies 2% finance 2% countries 1% stocks 1% technology brands 1%

Social topic influence how can #12, what are 6%, can you #310, to the #1132, how to 4%, in the 4%, health 4%, up to 4%, emerging 4%, future 3%

Top accounts mentioned or mentioned by @diabetologiajnl @rudolfdeboer @lorenzlehmann @medwirenews @danieljdrucker @naturerevendo @aliceyycheng @ucleye @moorfieldsbrc @ukhsa @escardio @springermedizin @springerhealth @springermed @bsl @biomedcentral @adisjournals @springerime @teresalpezfdez1 @springercurrpts

Top Social Posts

Top posts by engagements in the last [--] hours

"Insulin remains key to the management of type [--] diabetes but its role continues to evolve with the arrival of once-weekly regimens presenting new opportunities and challenges. How can once-weekly insulin therapy be implemented to optimize patient care"
X Link 2026-01-08T08:55Z [----] followers, 2.1M engagements

"Join leading expert Dr. Alice Cheng for practical insights into the safety efficacy and implementation of once-weekly insulin therapy for type [--] diabetes and how to optimize patient care"
X Link 2026-01-08T08:56Z [----] followers, 2.1M engagements

"Have you secured your place for our free webinar on the insulin toolkit for type [--] diabetes Register now to be the first to hear key insights from our expert faculty"
X Link 2026-01-08T08:59Z [----] followers, 2.3M engagements

"From #ADA2025 - The single-molecule dual GLP-1 and amylin receptor agonist #amycretin shows promising tolerability and weight loss when given orally or subcutaneously to adults with overweight or #obesity. Full story 👉 #MedNews #GLP1 https://buff.ly/xrEqw3N https://buff.ly/xrEqw3N"
X Link 2025-06-25T09:01Z [----] followers, [---] engagements

"Examine the existing definitions diagnostic criteria and clinical assessment methods currently used for #SarcopenicDysphagia plus the challenges to its current conceptualization. 👉 #Dysphagia #GastroTwitter https://buff.ly/xeHWiFI https://buff.ly/xeHWiFI"
X Link 2026-02-09T17:04Z [----] followers, [--] engagements

"#MedNews - Analysis of data from the PLCO cancer screening trial has revealed a significant association between higher lifetime drinking and an increased risk for #CRC. Full story 👉 #OncTwitter #GastroTwitter https://buff.ly/0FJ01vK https://buff.ly/0FJ01vK"
X Link 2026-02-09T20:45Z [----] followers, [--] engagements

"#IgAV can develop after the diagnosis of #IBD manifesting in the skin joints kidneys and GI tract but are people with IgAV at risk of IBD Investigate the interplay between the two including risk and protective factors. 👉 #GastroTwitter https://buff.ly/l89FTYR https://buff.ly/l89FTYR"
X Link 2026-02-10T09:10Z [----] followers, [--] engagements

"#MedNews - #Tirzepatide reduces the risk for and progression of diabetic #retinopathy compared with lifestyle intervention alone. Full story 👉 #EyeMed https://buff.ly/z6dDH8a https://buff.ly/z6dDH8a"
X Link 2026-02-10T14:24Z [----] followers, [--] engagements

"When the totality of the impact from environmental exposures are considered their detrimental effect to CV health are significant. What can be done to mitigate the risks of environmental exposures in both policy and the clinic 👉 #CardioTwitter https://buff.ly/wOZ9X1b https://buff.ly/wOZ9X1b"
X Link 2026-02-11T17:04Z [----] followers, [--] engagements

"Non-absorbable antimicrobials have shown limited efficacy in the eradication of multidrug resistant bacteria in the GI tract. This review outlines current and novel strategies as well as current knowledge gaps. 👉 #IDMed #GastroTwitter https://buff.ly/4CVKoll https://buff.ly/4CVKoll"
X Link 2026-02-12T14:24Z [----] followers, [--] engagements

"How can you optimize your patient care amidst a new era of insulin therapy Join our expert-led webinar to find out and have the opportunity to ask questions to fine-tune your clinical practice"
X Link 2026-01-08T09:10Z [----] followers, 1.4M engagements

"How can you optimize patient care when implementing once-weekly insulin therapy for the management of type [--] diabetes Our expert Dr. Alice Cheng discusses this and more in our upcoming live webinar"
X Link 2026-01-08T08:58Z [----] followers, 1.4M engagements

"Insulin therapy for type [--] diabetes is rapidly evolving. Is your clinical practice up to date Reserve your seat in our expert-led webinar and gain actionable insights to help improve your patient care"
X Link 2026-01-08T09:10Z [----] followers, 2M engagements

"How can you optimize your patient care amidst a new era of #insulin therapy Join our expert-led webinar to find out and have the opportunity to ask questions to fine-tune your clinical practice. Register for free 👉 #Diabetes #T2D https://buff.ly/SKALXgN https://buff.ly/SKALXgN"
X Link 2026-01-09T15:49Z [----] followers, [----] engagements

"#MedCase - Coronary aneurysms may present with nonspecific symptoms delaying appropriate management. A suspected cardiac tumor in this patient was revealed to be a giant RCA aneurysm which was successfully managed with surgery. 👉 #CardioTwitter https://buff.ly/Qy9Wk3M https://buff.ly/Qy9Wk3M"
X Link 2026-02-09T14:24Z [----] followers, [--] engagements

"#MedCase - Purtscher #retinopathy is usually related to trauma. But in this rare case cotton wool spots with few hemorrhages revealed left-eye Purtscherlike retinopathy developing after endogenous panophthalmitis in the right eye. 👉 #EyeMed https://buff.ly/Ryv8af6 https://buff.ly/Ryv8af6"
X Link 2026-02-10T17:04Z [----] followers, [--] engagements

"The bidirectional link between #diabetes and #periodontitis is well established but periodontitis remains underdiagnosed in the context of diabetes. Coordinated care could improve inflammation oral health and metabolic outcomes. 👉 #DiabetesMed https://buff.ly/aGFTjy3 https://buff.ly/aGFTjy3"
X Link 2026-02-11T09:10Z [----] followers, [--] engagements

"#MedCase - #Tularemia is typically linked to ticks hares and contaminated water or dust. In an unusual case from Southern Germany this patient developed headache chills fatigue and swollen lymph nodes following a squirrel bite. 👉 #IDMed https://buff.ly/iL66n9E https://buff.ly/iL66n9E"
X Link 2026-02-11T14:24Z [----] followers, [--] engagements

"#MedNews - #HPV testing of self-collected menstrual blood is as effective as conventional cervical screening for the detection of grade [--] or higher cervical intraepithelial neoplasia. Full story 👉 #OncTwitter #IDMed https://buff.ly/1HpvhAl https://buff.ly/1HpvhAl"
X Link 2026-02-12T09:10Z [----] followers, [--] engagements

"Prolonged topical antiglaucoma therapy can lead to significant deterioration of the ocular surface inducing dry eye hyperemia and other symptoms. This review outlines the underlying mechanisms and potential mitigation approaches. 👉 #EyeMed #Glaucoma https://buff.ly/gnFljnh https://buff.ly/gnFljnh"
X Link 2026-02-12T17:04Z [----] followers, [--] engagements

"#MedNews - Paramagnetic rim lesionsarelinked to a higher long-term riskfordeveloping clinical #MultipleSclerosis in people with radiologically isolated syndrome. Full story 👉 #NeuroTwitter https://buff.ly/nnKAdjz https://buff.ly/nnKAdjz"
X Link 2026-02-12T20:45Z [----] followers, [--] engagements

"❗LAST CHANCE TO REGISTER❗ What are the new opportunities and challenges that come with once-weekly #insulin regimens for type [--] #diabetes Dr @AliceYYCheng discusses their safety efficacy and implementation in this free webinar. 👉 #T2D #MedEd https://buff.ly/SLgxR2e https://buff.ly/SLgxR2e"
X Link 2026-02-13T09:10Z [----] followers, [--] engagements

"#MedNews - Approximately 10% of disorders of gutbrain interaction may be triggered by acute infectious #gastroenteritis with rates varying globally and by sociodemographic factors. Full story 👉 #GastroTwitter #IDMed https://buff.ly/4CJrzw3 https://buff.ly/4CJrzw3"
X Link 2026-02-13T14:24Z [----] followers, [--] engagements

"#MedCase - A continuous infusion of ATM-AVI following a full-vial loading dose was successful in treating a complex K. pneumoniae infection possibly providing a rational stewardship-conscious dosing approach for severe MBL infections. 👉 #IDMed https://buff.ly/4Kjkywy https://buff.ly/4Kjkywy"
X Link 2026-02-13T17:04Z [----] followers, [--] engagements

"Review the latest advances in fluid and neuroimaging biomarkers to better stratify hemorrhagic and cognitive risks in patients with cerebral amyloid angiopathy informing precision management. 👉 #NeuroTwitter #NeuroDiagnostics https://buff.ly/O9ML7uf https://buff.ly/O9ML7uf"
X Link 2026-02-13T20:45Z [----] followers, [--] engagements

"#MedNews - The oral PCSK9 inhibitor #enlicitide significantly reduces LDL-C levels in people with a history of or risk for #ASCVD events. Full story 👉 #CardioTwitter https://buff.ly/sJ66lnS https://buff.ly/sJ66lnS"
X Link 2026-02-14T09:10Z [----] followers, [--] engagements

"Bispecific antibodydrug conjugates represent a promising strategy to overcome the limitations of conventional #ADCs in #BreastCancer such as tumor heterogeneity and inefficient internalization. Full story 👉 #OncTwitter https://buff.ly/i0BbRzZ https://buff.ly/i0BbRzZ"
X Link 2026-02-14T14:24Z [----] followers, [--] engagements

"#MedCase - An unusual case of Vogt-Koyanagi-Harada syndrome emerging after a trip above [----] m presenting with low visual acuity conjunctival injection and retinal detachment. 👉 #EyeMed https://buff.ly/iR227PB https://buff.ly/iR227PB"
X Link 2026-02-14T17:04Z [----] followers, [---] engagements

"#MedNews - The siRNA therapeutic #inclisiran significantly reduces LDL-C vs placebo in adolescents undergoing treatment for heterozygous familial #hypercholesterolemia according to the findings of the ORION-16 study. Full story 👉 #CardioTwitter https://buff.ly/pjhNy7T https://buff.ly/pjhNy7T"
X Link 2026-02-15T09:10Z [----] followers, [--] engagements

"Interstitial lung disease is the most severe extra-articular manifestations of rheumatoid #arthritis. What is known about its pathogenesis and how does that inform treatment options 👉 #ILD #PulmTwitter https://buff.ly/fJXbnJU https://buff.ly/fJXbnJU"
X Link 2026-02-15T14:24Z [----] followers, [--] engagements

"#MedNews - #Tenecteplase thrombolysis is no more effective than aspirin for treating acute central retinal artery occlusion and is associated with safety concerns. Full story 👉 #EyeMed https://buff.ly/e3JWECs https://buff.ly/e3JWECs"
X Link 2026-02-15T17:04Z [----] followers, [---] engagements

"#Semaglutide therapy achieved weight loss & reduced cocaine craving in a man with #obesity & chronic cocaine abuse. Could this be a new strategy to address substance craving in patients with comorbid obesity Find out more in this #EdsChoice case. 👉 https://buff.ly/4kgM4PI https://buff.ly/4kgM4PI"
X Link 2025-02-25T17:04Z [----] followers, [---] engagements

"Global prevalence of #myopia in children & adolescents is set to reach 40% by [----] Dr. Annegret Dahlmann-Noor explores the reasons behind this increase and what we can do to halt the trend. Listen now 👉 #EyeCare #EyeTwitter @UCLeye @MoorfieldsBRC https://buff.ly/oInKRYI https://buff.ly/oInKRYI"
X Link 2025-04-15T12:02Z [----] followers, [---] engagements

"Explore the clinical potential of type [--] #diabetes-related PGSs for risk prediction and screening of #T2D and its comorbidities and risk stratification with attention to their global applicability in this #EdsChoice review from @DiabetologiaJnl 👇 https://buff.ly/ZFrNasA https://buff.ly/ZFrNasA"
X Link 2025-04-19T13:24Z [----] followers, [---] engagements

"Join our live webinar to learn more about the novel biomarkers for diagnosis and treatment of #lupus and familiarize yourself with current and emerging targeted therapies. Register now 👉 #MedTwitter #RheumTwitter #MedEd https://buff.ly/AL82nY0 https://buff.ly/AL82nY0"
X Link 2025-05-21T08:01Z [----] followers, [---] engagements

"❗LAST CHANCE TO REGISTER❗ Join us later today to get up to date on the novel biomarkers for diagnosis and monitoring and current and emerging targeted therapies for systemic #lupus erythematosus. #RheumTwitter #MedEd #MedWebinar #Lupus2025 https://buff.ly/AL82nY0 https://buff.ly/AL82nY0"
X Link 2025-05-27T06:30Z [----] followers, [---] engagements

"What were the highlights from the recent #ASCO Annual Meeting Keep up to date with all the top stories latest evidence and key highlights with our #ASCO25 hub page. Explore the hub here 👉 #oncology #cancer #meded https://buff.ly/SFiWKZB https://buff.ly/SFiWKZB"
X Link 2025-06-04T08:10Z [----] followers, [----] engagements

"The diagnostic and treatment landscape for #RetinalDiseases is rapidly evolving. Explore groundbreaking advances in retinal imaging and gene therapy before taking a deep dive into emerging treatments for wet #AMD. Register now 👉 #Ophthalmology #EyeMed https://buff.ly/4CCsXfv https://buff.ly/4CCsXfv"
X Link 2025-06-06T10:01Z [----] followers, [---] engagements

"#MedCase - Neuropsychiatric #SLE and infections such as #WestNile encephalitis can be difficult to differentiate as demonstrated by these cases. This is a vital challenge to overcome due to the opposing management strategies. 👉 #EdsChoice #Lupus https://buff.ly/kSJYPRj https://buff.ly/kSJYPRj"
X Link 2025-06-19T16:06Z [----] followers, [---] engagements

"#MedNews - Treatment with #inclisiran a PCSK9 protein blocker significantly reduces low-density lipoprotein cholesterol in adults at low risk for #ASCVD. Full story 👉 #CardioTwitter https://buff.ly/p4S9fcn https://buff.ly/p4S9fcn"
X Link 2025-06-24T13:24Z [----] followers, [--] engagements

"Catch up on the latest news and key highlights from #EAN2025 with our hub page. Access the hub for free here 👉 #NeuroTwitter #MedNews https://buff.ly/NZ20rXr https://buff.ly/NZ20rXr"
X Link 2025-06-24T15:15Z [----] followers, [---] engagements

"Catch up on the latest breakthroughs in #diabetes research from the #ADA2025 Annual Meeting with our hub page. Access the hub for free here 👉 #EndoTwitter #MedTwitter #MedNews https://buff.ly/hNpwEZv https://buff.ly/hNpwEZv"
X Link 2025-06-25T08:10Z [----] followers, [--] engagements

"England has rolled out the world's first vaccination program against #gonorrhea. Dr. Hamish Mohammed from the @UKHSA discusses how a multi-pronged approach is needed to reduce the number of cases and combat the threat of #AntibioticResistance. #STIs https://buff.ly/jjB6pq4 https://buff.ly/jjB6pq4"
X Link 2025-08-14T13:40Z [----] followers, [----] engagements

"We talk to Prof. Messoud Ashina about #PACAP signaling and why targeting it might be the next big breakthrough for sustained #migraine control. Full episode out now 👉 #NeuroTwitter #headache https://buff.ly/Bauo10V https://buff.ly/Bauo10V"
X Link 2025-09-01T16:04Z [----] followers, [---] engagements

"#FND perplexes patients and physicians alike. Join Prof. Mark Edwards in our free webinar for a comprehensive overview of how to recognize FND communicate the diagnosis effectively and help patients manage the disorder. Register now 👉 #NeuroTwitter https://buff.ly/WRX62NH https://buff.ly/WRX62NH"
X Link 2025-09-04T15:00Z [----] followers, [----] engagements

"In our latest podcast we talk to Prof. Messoud Ashina about #PACAP signaling and why targeting it might be the next big breakthrough for sustained #migraine control. Listen now 🔉 #NeuroMed #MedPodcast https://buff.ly/Bauo10V https://buff.ly/Bauo10V"
X Link 2025-09-15T08:10Z [----] followers, [---] engagements

"What are the best treatment options for your patients with #FND Prof. Mark Edwards discusses this and more in our upcoming live webinar. Register for free 👉 #NeuroTwitter #NeuroMed #MedEd https://buff.ly/bF2uOeh https://buff.ly/bF2uOeh"
X Link 2025-10-08T13:24Z [----] followers, [---] engagements

"From #ESMO2025 - Dr. Erica Mayer highlights the benefit of treatment with #giredestrant plus #everolimus in patients with ER-positive HER2-negative advanced #BreastCancer who have previously received a CDK4/6 inhibitor. Watch now 👉 #MedNews https://buff.ly/rblPhdk https://buff.ly/rblPhdk"
X Link 2025-11-03T14:24Z [----] followers, [---] engagements

"Our first live webinar on 16th May (17:30 CEST) Spotlight on Cardio-Oncology will see @rudolf_deboer @LorenzLehmann and Teresa Lopz Ferndez discuss the most pertinent issues in cardio-oncology with a focus on the new @escardio guidelines: 8/10 http://bit.ly/40az9V0 http://bit.ly/40az9V0"
X Link 2023-03-22T14:35Z [----] followers, [---] engagements

"A joint initiative of @SpringerMedizin @SpringerHealth @SpringerMed and @BSL Springer Medicine is proud to work with Springer @medwireNews @BioMedCentral @AdisJournals and @SpringerIME. 9/10"
X Link 2023-03-22T14:35Z [----] followers, [---] engagements

"The on-demand recording of our first webinar Spotlight on Cardio-Oncology is available Join @rudolf_deboer @LorenzLehmann and @TeresaLpezFdez1 as they discuss how to best care for cancer patients at risk of cardiovascular complications. #cardiooncology #MedEd #MedTwitter"
X Link 2023-06-02T10:40Z [----] followers, [----] engagements

"Using 5+ daily medications is common in #MultipleSclerosis but drugdrug interactions and additive side effects make it risky. This #EdsChoice review sets out the prevalence consequences and approaches for #Neurology @SpringerCurRpts http://bit.ly/3QAO5tp http://bit.ly/3QAO5tp"
X Link 2023-08-11T14:31Z [----] followers, [---] engagements

"From #EASD2023 - A network meta-analysis indicates that tirzepatide is likely superior to semaglutide for #Type2Diabetes reductions in HbA1c and weight loss Full story below #EdsChoice #DiabetesTwitter #MedNews https://bit.ly/3ZPO3jW https://bit.ly/3ZPO3jW"
X Link 2023-10-11T14:48Z [----] followers, [---] engagements

"Join our expert-led webinar on the prevention and management of type [--] diabetes through dietary interventions with an exploration of the psychological factors that influence patient success. Register now below #diabetes #T2D #MedEd #MedTwitter"
X Link 2023-10-17T15:15Z [----] followers, [---] engagements

"Attending #ESMO23 Drop by stand [---] to meet our team and learn more about our free #MedEd platform. Sign up now for access to breaking medical news congress coverage #CME programs and content from leading #oncology journals using the link below http://bit.ly/3teZfdM http://bit.ly/3teZfdM"
X Link 2023-10-22T09:22Z [----] followers, [---] engagements

"Exclusive Interview - @drenriquegrande discusses the recent advancements in the treatment of urothelial cancers brought on by the findings of the EV-302 and CheckMate [---] trials presented at #ESMO23 Full interview here - #Oncology #OncoTwitter #MedNews https://bit.ly/46SfPza https://bit.ly/46SfPza"
X Link 2023-11-01T12:51Z [----] followers, [----] engagements

"Continuous renal replacement therapy is preferred for renal support in critically ill and hemodynamically unstable children but practice varies widely. What should pediatricians know #Pediatrics @EurJPediatrics @ChanchlaniRahul @aakashdeeparora https://bit.ly/413v0mU https://bit.ly/413v0mU"
X Link 2023-12-04T11:11Z [----] followers, [---] engagements

"Could stringent control of dyslipidemia in children with type [--] diabetes prevent early-onset atherosclerotic cardiovascular disease What can we learn from early initiation of statins in familial hypercholesterolemia #EdsChoice #T1D @DiabetologiaJnl https://bit.ly/3uMCApX https://bit.ly/3uMCApX"
X Link 2023-12-08T16:38Z [----] followers, [---] engagements

"Join our upcoming live webinar on #ADCs and delve into their mechanism of action with the experts. We will discuss efficacy & safety data from clinical trials in breast & lung cancer settings and explore current challenges. #Oncology #Oncologists #MedEd #LungCancer #BreastCancer"
X Link 2024-01-15T13:12Z [----] followers, [---] engagements

"#MedNews - Two doses of the recombinant zoster vaccine are 76% effective at protecting against incident herpes zoster with protection maintained over a 4-year period. Full story #EdsChoice #Shingles #herpeszoster https://go.sn.pub/FPr8uT https://go.sn.pub/FPr8uT"
X Link 2024-01-30T17:00Z [----] followers, [---] engagements

"#MedNews - A plasma p-tau217 immunoassay offers comparative diagnostic accuracy for #AlzheimersDisease pathologies to that of cerebrospinal fluid #biomarkers with a reduced need for advanced confirmatory testing. Full story #Neurology #NeuroTwitter https://go.sn.pub/xiDO09 https://go.sn.pub/xiDO09"
X Link 2024-02-01T16:22Z [----] followers, [---] engagements

"#MedNews - Phase [--] trial shows [--] weeks of treatment with NALL improves the neurologic status of patients with NiemannPick disease type C Full story ➡ #Neurology #NiemannPick https://go.sn.pub/1SFBdh https://go.sn.pub/1SFBdh"
X Link 2024-02-15T10:44Z [----] followers, [---] engagements

"What are the potential complications of the different #palliative interventions for malignant #PleuralEffusion and how can clinicians mitigate and manage them Schwalk et al. summarize in this #EdsChoice review: #RespMed #PalliativeCare @aggie07girl https://go.sn.pub/gP7ZyZ https://go.sn.pub/gP7ZyZ"
X Link 2024-02-24T16:00Z [----] followers, [----] engagements

"How does the gut microbiome affect the efficacy of CAR T-cell therapy in patients with hematological malignancies Prof. @MSubklewe discusses in our podcast. Full episode available below 👉 👈 #OncTwitter #BloodCancer #HaemOnc http://bit.ly/42S9xy1 http://bit.ly/42S9xy1"
X Link 2024-03-03T09:00Z [----] followers, [---] engagements

"@fatemehsaneiyan Hi @fatemehsaneiyan the live webinar will be online May 2nd with the recording available online soon after"
X Link 2024-03-11T08:00Z [----] followers, [---] engagements

"Could blood or plasma transfusion from young healthy donors successfully treat neurodegenerative diseases Explore the evidence in this #EdsChoice review. #NeuroTwitter #Alzheimers #HuntingtonsDisease @crchuqc https://go.sn.pub/PNWxkd https://go.sn.pub/PNWxkd"
X Link 2024-05-01T13:12Z [----] followers, [---] engagements

"Dr. Dieras shares her hopes for the future of #ADCs treatment in #cancer in our on-demand webinar. Learn the mechanisms key clinical trials and current challenges and future directions in the full recording. #OncTwitter #Oncology #CancerMedicine https://go.sn.pub/4866nj https://go.sn.pub/4866nj"
X Link 2024-06-03T09:00Z [----] followers, [---] engagements

"What are the key drivers in #medication non-adherence and how can you work with your patients to overcome them Join us as our experts discuss & offer an in-depth look at medication adherence in two example scenarios: #hypertension & #asthma control. #HCPs #MedEd #PatientCare"
X Link 2024-06-07T15:00Z [----] followers, [---] engagements

"Increased understanding of the genetic factors and pathogenesis underlying #ALS is driving development of novel therapeutic approaches. Delve into the current studies & future horizons in this #EdsChoice review: #NeuroTwitter #MND #MNDisease https://go.sn.pub/rec1mn https://go.sn.pub/rec1mn"
X Link 2024-06-10T09:00Z [----] followers, [---] engagements

"There is still time to sign-up for our live-webinar on #medication adherence Join our experts as they delve into the drivers of non-adherence among patients and take an in-depth look at adherence in #asthma and #hypertension populations. #MedEd #HCPs #PatientCare"
X Link 2024-06-21T09:00Z [----] followers, [---] engagements

"The use of #diabetes therapeutic technology is being advocated for older people but what are the benefits & challenges of implementing such solutions Explore in this #EdsChoice review from @DiabetologiaJnl #DiabetesTech #EndoTwitter #MedTech https://go.sn.pub/4vt3za https://go.sn.pub/4vt3za"
X Link 2024-08-15T15:38Z [----] followers, [---] engagements

"This joint EASD/ISPAD position statement published in @DiabetologiaJnl provides general & device-specific guidance to help AID systems be used effectively in people with #T1D to manage physical activity & exercise. #Diabetes #Insulin #EASD https://go.sn.pub/0nbu8y https://go.sn.pub/0nbu8y"
X Link 2024-12-16T14:00Z [----] followers, [---] engagements

"Diagnosis of #PCNSL can be challenging but genomic cfDNA testing on CSF has emerged as a new tool. Explore how both diagnostics & treatments have evolved in this #EdsChoice review. #Lymphoma #NeuroTwitter #OncTwitter https://go.sn.pub/ywkzq4 https://go.sn.pub/ywkzq4"
X Link 2024-12-17T09:00Z [----] followers, [--] engagements

"#MedNews - Serum GFAP & UCH-L1 levels above the reference range may help predict clinically important traumatic brain injury in children with mild #TBI. Full story #NeuroTwitter #PediatricMed https://go.sn.pub/1eydvw https://go.sn.pub/1eydvw"
X Link 2025-01-02T11:16Z [----] followers, [--] engagements

"Treating acanthamoeba #keratitis is challenging with conventional therapies often ineffective. This #EdsChoice explores a novel treatment combining PACK-CXL with both riboflavin/UV-A & rose bengal/green light in a single procedure. 👉 #Ophthalmology https://buff.ly/42nX3Al https://buff.ly/42nX3Al"
X Link 2025-01-20T17:04Z [----] followers, [---] engagements

"Explore the evidence-based recommendations for #PCOS in adolescents including screening diagnosis and risk assessment with this #EdsChoice review. 👉 #EndoTwitter #GyneTwitter #MedTwitter https://buff.ly/VLgTHW7 https://buff.ly/VLgTHW7"
X Link 2025-03-21T09:10Z [----] followers, [--] engagements

"Of the current treatments for #lupus nephritis how many can be classed as disease modifying according to recently proposed criteria And what are the challenges and considerations for future studies Explore in this #EdsChoice review 👉 #RheumTwitter https://buff.ly/Ll0EgsE https://buff.ly/Ll0EgsE"
X Link 2025-04-23T13:24Z [----] followers, [---] engagements

"We talk with Prof. @DanielJDrucker about the early work on GLP-1 medicines for the treatment of #diabetes the impact on the lives of people living with #obesity and their potential use for many other indications. Listen now 👉 #GLP1RA @NatureRevEndo https://buff.ly/lFsXRAV https://buff.ly/lFsXRAV"
X Link 2025-05-20T10:30Z [----] followers, [----] engagements

"Have you listened to the latest ep of Medicine Matters Prof. @DanielJDrucker discusses the early work on GLP-1 medicines for the treatment of #diabetes #obesity and their potential use for many other indications. Listen now 👉 #GLP1RA @NatureRevEndo https://buff.ly/lFsXRAV https://buff.ly/lFsXRAV"
X Link 2025-06-02T08:10Z [----] followers, [---] engagements

"Catch up on the top stories and recent findings in #rheumatology from #EULAR2025 with our hub page. Access for free 👉 #RheumTwitter #MedTwitter #MedNews https://buff.ly/FQgNaVd https://buff.ly/FQgNaVd"
X Link 2025-06-18T09:30Z [----] followers, [---] engagements

"ICIs in #cancer: what lies beyond monoclonal antibodies Alternative strategies such as small-molecule inhibitors #aptamers gene-editing and more are being explored to overcome the limitations of monoclonal antibody-based #ICI. #EdsChoice #Oncology https://buff.ly/vtrydPC https://buff.ly/vtrydPC"
X Link 2025-06-30T08:10Z [----] followers, [---] engagements

"#MedNews - Genetic analysis of patients with uveal melanoma suggests the cancer might be part of the #LynchSyndrome spectrum and therefore patients could benefit from germline testing. 👉 #EyeMed #OncTwitter https://buff.ly/tjRW4KG https://buff.ly/tjRW4KG"
X Link 2025-06-30T16:08Z [----] followers, [---] engagements

"There is still time to register for our upcoming webinar on the recent innovations in diagnosis and treatment of retinal diseases Find out more here 👉 #EyeMed #RetinalDisease #MedEd https://buff.ly/BSZphUA https://buff.ly/BSZphUA"
X Link 2025-07-01T08:10Z [----] followers, [---] engagements

"#MedNews - Initiating DOACs within [--] days of acute ischemic #stroke in patients with atrial fibrillation significantly reduces the risk of recurrent stroke symptomatic ICH or unclassified stroke. Full story 👉 #NeuroTwitter #CardioTwitter https://buff.ly/gMWtlxZ https://buff.ly/gMWtlxZ"
X Link 2025-07-16T13:24Z [----] followers, [--] engagements

"A growing subset of patients with #T1D are developing insulin resistance. Discover how this may accelerate progression toward steatohepatitis fibrosis and CV complications. 👉 #MASLD #Diabates #EdsChoice https://buff.ly/NWuCzCz https://buff.ly/NWuCzCz"
X Link 2025-07-16T16:06Z [----] followers, [--] engagements

"Bleeding and thrombotic complications are not uncommon with #immunotherapy. Understand the epidemiology clinical manifestations pathologic mechanisms and management principles to enhance your decision-making. 👉 #OncTwitter #EdsChoice https://buff.ly/fLriXf8 https://buff.ly/fLriXf8"
X Link 2025-07-17T13:25Z [----] followers, [--] engagements

"This review from @DiabetologiaJnl highlights ethnic disparities in #diabetes risk diagnosis and treatment advocating for inclusive #PrecisionMedicine models that integrate ancestry phenotype and sociocultural context to improve equity and outcomes. https://buff.ly/xaGUPFM https://buff.ly/xaGUPFM"
X Link 2025-08-27T08:10Z [----] followers, [---] engagements

"How can you best treat functional neurological disorder (FND) Join our expert-led webinar to increase your confidence in recognizing #FND communicating the diagnosis effectively and helping your patients manage the disorder. 👉 #NeuroTwitter #MedEd https://buff.ly/CkDPvBO https://buff.ly/CkDPvBO"
X Link 2025-09-25T13:24Z [----] followers, [---] engagements

"#MedNews - Low-dose #aspirin significantly reduced the risk for colorectal #cancer recurrence in people with alterations in PI3K pathway genes in the ALASCCA trial. Full story 👉 #OncTwitter #CRC https://buff.ly/FJcN9hw https://buff.ly/FJcN9hw"
X Link 2025-09-28T19:45Z [----] followers, [---] engagements

"Beyond lipid-lowering #statins have anti-inflammatory endothelial-stabilizing & neuroprotective actions that may reduce recurrence improve survival & preserve cognition after AIS. Discover innovations aiming to realize their potential. 👉 #Stroke https://buff.ly/cqB5OV5 https://buff.ly/cqB5OV5"
X Link 2025-09-29T16:04Z [----] followers, [---] engagements

"Refine your approach to diagnosing brief recurring neurological symptoms by identifying key features of common causes such as TIAs #seizures & #migraine auras & understanding the differential diagnosis for rarer #ParoxysmalDisorders 👉 #NeuroTwitter https://buff.ly/xwn1BXx https://buff.ly/xwn1BXx"
X Link 2025-10-08T16:05Z [----] followers, [---] engagements

"#MedNews - Seven-year data from PARTNER [--] show #TAVR and surgery have similar long-term outcomes in low-risk patients with severe aortic stenosis. Full story 👉 #CardioTwitter #VHD https://buff.ly/bp5yBD7 https://buff.ly/bp5yBD7"
X Link 2025-11-10T14:24Z [----] followers, [---] engagements

"Take a deep dive into the rapidly evolving world of therapeutic #CancerVaccines with Dr. Elias Sayour and find out why he is so excited about upcoming developments. Listen now 🔉 #OncTwitter #CancerTherapy https://buff.ly/qnrci2N https://buff.ly/qnrci2N"
X Link 2026-01-30T17:04Z [----] followers, [--] engagements

"#MedNews - #SGLT2 inhibitors may offer greater protection against acute and chronic kidney outcomes than #GLP1 receptor agonists in people with #Type2Diabetes. Full story 👉 #T2D https://buff.ly/m1oOFvG https://buff.ly/m1oOFvG"
X Link 2026-02-05T09:10Z [----] followers, [--] engagements

"How do bacteria contribute to oncogenesis From the mechanistic contributions of pathogenic bacteria to tumor initiation to the role dysbiosis plays in influencing systemic #cancer behavior understand the impact with this review. 👉 #OncTwitter #IDMed https://buff.ly/72lJgxT https://buff.ly/72lJgxT"
X Link 2026-02-07T09:10Z [----] followers, [--] engagements

"In our latest podcast @medwirenews talks to Prof. Malin Parmar of @Lund_Stem about why stem cell therapy is such a good option for patients with Parkinsons disease and gets an update on the STEM-PD trial. #Parkinsons #Neurology #NeuroTwitter"
X Link 2023-09-15T09:36Z [----] followers, [---] engagements

"Trigeminal postherpetic neuralgia is a persistent & debilitating #neuropathic pain condition. This #EdsChoice Review explores its clinical characteristics pathophysiological underpinnings and existing & potential therapies. #Neurology #NeuroTwitter https://go.sn.pub/oJGjD6 https://go.sn.pub/oJGjD6"
X Link 2024-02-04T10:00Z [----] followers, [---] engagements

"Quality #sleep is essential for health but how does it protect our brains & what happens when sleep patterns are disturbed Join our expert-led webinar as we explore the link between sleep & neurological diseases. Register now - #Somnology #NeuroTwitter https://go.sn.pub/XnvyBM https://go.sn.pub/XnvyBM"
X Link 2024-03-11T14:00Z [----] followers, [----] engagements

"Time is almost up to register for our #sleep in brain health webinar Join us as we delve into the links between sleep & neurological disease the signs of sleep disruption #HCPs are most likely to see & how to prevent its harmful effects in patients. #NeuroTwitter #MedEd"
X Link 2024-05-01T11:00Z [----] followers, [---] engagements

"#MedNews - Long-term #SGLT2 inhibitor use is associated with an increased risk for postoperative euglycemic #ketoacidosis but lower risks for postoperative acute kidney injury and mortality. Full story 👉 #MedTwitter #AKI https://buff.ly/m5clqKQ https://buff.ly/m5clqKQ"
X Link 2025-05-16T13:24Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing